Sick With Something That Isn ’ t COVID-19 or the Flu? Here ’ s What It Might Be
Flu season is wrapping up, and weekly COVID-19 diagnoses are declining. But if you’re currently sick with a respiratory illness, you’re not alone.
Data from the U.S. Centers for Disease Control and Prevention (CDC) show that a mixture of respiratory viruses are circulating right now, including common coronaviruses (other than SARS-CoV-2, which causes COVID-19), respiratory adenovirus, and parainfluenza (which is distinct from influenza).
All of these viruses can cause cold-like symptoms including fever, runny nose, sore throat, and cough, so “it’s very, very hard to tell the difference between any o...
Source: TIME: Health - March 20, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Disease healthscienceclimate Source Type: news
Virus outbreak in West Bengal leaves 19 children dead and thousands in hospital
Indian state in crisis after adenovirus hits 12,000 people this year and families with sick children camp outside Kolkata hospitalNineteen children have died of acute respiratory infections in West Bengal this year, and thousands more are in hospital as India grapples with an adenovirus outbreak.More than 12,000 cases of adenovirus have been recorded in the state since January. More than 3,000 children have been admitted to hospital with severe flu-like symptoms.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 15, 2023 Category: Science Authors: Puja Bhattacharjee in Kolkata Tags: Global health Global development India South and central Asia World news Infectious diseases Microbiology Science Source Type: news
Gene Therapy Beneficial for Patients With Hemophilia B
FRIDAY, March 3, 2023 -- For patients with hemophilia B, one infusion of adeno-associated virus 5 (AAV5) vector expressing the Padua factor IX variant (etranacogene dezaparvovec) is noninferior and superior to prophylaxis with factor IX, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 3, 2023 Category: Pharmaceuticals Source Type: news
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need
Partnership Combines AbbVie's extensive capabilities with Capsida's novel adeno-associated virus (AAV) engineering platform
Builds upon the neurodegenerative disease partnership announced in 2021
NORTH CHICAGO, Ill. and THOUSAND OAKS, Calif., Feb. 23... Biopharmaceuticals, Ophthalmology AbbVie, Capsida Biotherapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 23, 2023 Category: Pharmaceuticals Source Type: news
Ad26.RSV.preF-RSV preF Protein Vaccine Immunogenic in Seniors
THURSDAY, Feb. 16, 2023 -- An adenovirus serotype 26 respiratory syncytial virus (RSV) vector encoding a prefusion F (preF) protein (Ad26.RSV.preF) in combination with RSV preF protein is immunogenic and prevents RSV-mediated lower respiratory tract... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 16, 2023 Category: Pharmaceuticals Source Type: news
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
LEIDEN, THE NETHERLANDS, (January 18, 2023) – The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, today announced the results of an independent, scheduled data review of the Phase 3 Mosaico study (also known as HPX3002/HVTN706) of Janssen’s investigational HIV vaccine regimen. The study’s independent Data and Safety Monitoring Board (DSMB) determined that the regimen was not effective in preventing HIV infection compared to placebo among study participants. No safety issues with the vaccine regimen were identified.In light of the DSMB’s determination, the Mo...
Source: Johnson and Johnson - January 18, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Recombinant adeno-associated virus (rAAV) technology pioneered by AskBio's Dr. Jude Samulski is key component of all FDA approved AAV gene therapeutics
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly-owned and independently-operated subsidiary of Bayer AG, today announced that the FDA's approval of a new adeno-associated virus (AAV) gene therapy to treat adults with hemophilia B marks another milestone for the advancement of AAV therapeutics and highlights the important research contributions made by AskBio Co-Founder, President and Chief Scientific Officer, R. Jude Samulski, PhD. (Source: World Pharma News)
Source: World Pharma News - December 20, 2022 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news
FDA Approves Adstiladrin (nadofaragene firadenovec-vncg) for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Ferring’s novel adenovirus vector-based gene therapy Adstiladrin® (nadofaragene firadenovec-vncg) is the first gene therapy approved for bladder cancer
Efficacy and safety of Adstiladrin supported by Phase 3 results demonstrating that... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 16, 2022 Category: Drugs & Pharmacology Source Type: news
Monthly News Roundup - November 2022
FDA Approves Hemgenix, a Historic, One-Time Gene Therapy for Hemophilia B
In November, the U.S. Food and Drug Administration (FDA) approved CSL Behring’s Hemgenix (etranacogene dezaparvovec-drlb), an adeno-associated virus vector-based gene... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 30, 2022 Category: Pharmaceuticals Source Type: news
FDA Approves First Gene Therapy for Adults With Hemophilia B
MONDAY, Nov. 28, 2022 -- The U.S. Food and Drug Administration has approved Hemgenix (etranacogene dezaparvovec) for the treatment of hemophilia B in adults.
Hemgenix, an adeno-associated virus vector-based gene therapy, is administered via... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 28, 2022 Category: General Medicine Source Type: news
FDA Approves First Gene Therapy, Hemgenix, for Adults With Hemophilia B
MONDAY, Nov. 28, 2022 -- The U.S. Food and Drug Administration has approved Hemgenix (etranacogene dezaparvovec) for the treatment of hemophilia B in adults.
Hemgenix, an adeno-associated virus vector-based gene therapy, is administered via... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news
FDA approves first gene therapy to treat adults with Hemophilia B
Today, the U.S. Food and Drug Administration approved Hemgenix (etranacogene dezaparvovec), an adeno-associated virus vector-based gene therapy for the treatment of adults with Hemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes. (Source: World Pharma News)
Source: World Pharma News - November 22, 2022 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
Ohio boy, 2, is hospitalized after being infected by THREE viruses at the same time
Wilder Jackson, 2, of Middletown, Ohio - just 30 miles north of Cincinnati, was simultaneously battling rhinovirus, enterovirus and adenovirus. (Source: the Mail online | Health)
Source: the Mail online | Health - October 28, 2022 Category: Consumer Health News Source Type: news
Can your child's respiratory infection can be treated at home? How to know
A common respiratory virus, respiratory syncytial virus, is surging in the United States, leading to some children's hospitals being overwhelmed. The influenza virus is also on the rise, along with other viruses — such as adenovirus and rhinovirus — that cause the common cold. (Source: CNN.com - Health)
Source: CNN.com - Health - October 28, 2022 Category: Consumer Health News Source Type: news
Meeting the Increasing Manufacturing Demands of the Rapidly Growing...
In this free webinar, learn about the rapidly growing cell and gene therapy and vaccine markets. Attendees will get an overview of the manufacturing process for adeno-associated virus (AAV) and how...(PRWeb October 28, 2022)Read the full story at https://www.prweb.com/releases/meeting_the_increasing_manufacturing_demands_of_the_rapidly_growing_cell_and_gene_therapy_and_vaccine_markets_upcoming_webinar_hosted_by_xtalks/prweb18986112.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 28, 2022 Category: Pharmaceuticals Source Type: news
